| Scleroderma Foundation's 13th Annual National Patient Education Conference Is Here |
 |
 |
 |
| Wednesday, 06 July 2011 10:01 |
|
Nearly 600 people are anticipated to visit the heart of San Francisco Friday, July 8, through Sunday, July 10, for the Scleroderma Foundation's 13th Annual National Patient Education Conference. Patients, family members, caregivers, doctors and other health care professionals representing 40 states, the District of Columbia, Canada and Mexico will converge at the Hilton San Francisco Union Square for this engaging and educational event that focuses on scleroderma, a rare autoimmune disease.
This year's conference features a variety of workshops hosted by leading scleroderma researchers and medical professionals. Andreas Baxevanis, Ph.D., will give the opening keynote address on the promise of genomics and genome-based personal health care in disease management. James Lemons, Ed.D., will present the closing keynote on "Pain – The Psychology and Physiology: There is Hope." Dr. Baxevanis is Assistant Director for Computational Bioscience, Office of Intramural Research at the National Institutes of Health (NIH), and Associate Investigator, Division of Intramural Research at the National Human Genome Research Institute in Bethesda, Md. Dr. Lemons is the director of The Lemons Center for Behavioral Pain Management in Lenexa, Kan., and a medical psychologist. Other conference highlights include:
For more information about scleroderma and the National Patient Education Conference, visit www.scleroderma.org. |
More articles :
» Special Surgery Scientists To Share Advances in Lupus and Related Conditions
Hospital for Special Surgery physicians who focus on lupus, scleroderma and related conditions are traveling from New York City to Atlanta this week to share their recent findings at the 74th Annual Scientific Meeting of the American College of...
» Making A Connection Between Depression and Inflammation
The dramatic rise in depression diagnoses over the last two decades is a great challenge to modern medicine. I believe that part of the "depression epidemic" is false - a creation of aggressive disease-mongering by pharmaceutical companies to...
» Biomarkers Predict Lung Decline in Systemic Sclerosis
Predicting risk of pulmonary fibrosis and pulmonary hypertension is an urgent priority in systemic sclerosis. Lung function often declines rapidly in the first years after diagnosis, and interstitial lung disease (ILD), although highly variable in...
» A Positive Approach To Scleroderma
Several years ago, was asked the question, "What are your recommendations for treatment or living with a new diagnosis of ?" The following was his answer, which is still relevant today.As you know, there is no cure for Scleroderma and no...
» Placebo-controlled Study of Methotrexate in Juvenile Localised Scleroderma
According to the results of this placebo-controlled study, is an effective treatment for juvenile localised scleroderma (JLS). The authors note that JLS is a chronic progressive fibrotic process of the skin causing permanent disability and...
» Scleroderma and Pregnancy
In an ideal world, men and women would be able to start their families with no difficulties or problems. However, there are many issues that can complicate matters and Scleroderma and Pregnancy is one of those issues. It is very important to...